The Great Britain is witnessing a significant surge in interest surrounding copyright substances. Beyond the well-established use of psilocybin and LSD, researchers and adventurers are increasingly delving into less-charted areas, particularly copyright and the relatively new cannabinoid, CBG. This burgeoning movement encompasses therapeutic resear